We are live on ! Find out more
WX

WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX

Delisted

WX was delisted on the 10th of December, 2015.

Back to rankings

154 hedge funds and large institutions have $1.91B invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2014 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 57 increasing their positions, 66 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more call options, than puts

Call options by funds: $3.56M | Put options by funds: $1.6M

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

6% less funds holding

Funds holding: 164 → 154 (-10)

12% less capital invested

Capital invested by funds: $2.17B → $1.91B (-$265M)

14% less repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 66

38% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 26

Holders
154
Holders Change
-10
Holders Change %
-6.1%
% of All Funds
4.43%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.17%
New
16
Increased
57
Reduced
66
Closed
26
Calls
$3.56M
Puts
$1.6M
Net Calls
+$1.95M
Net Calls Change
+$2.3M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$82.7M
2
Ninety One (UK)
Ninety One (UK)
United Kingdom
+$40M
3
CCM
Consonance Capital Management
New York
+$24.4M
4
RFC
Russell Frank Company
Washington
+$22M
5
Fidelity International
Fidelity International
Bermuda
+$18.3M

Top Sellers

Rank Fund Capital Flow
1
CI Investments Inc
CI Investments Inc
Ontario, Canada
-$54.7M
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$35.7M
3
Principal Financial Group
Principal Financial Group
Iowa
-$34.8M
4
William Blair & Company
William Blair & Company
Illinois
-$26.7M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$25.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Marshall Wace
51
Marshall Wace
United Kingdom
$4.95M +$4.57M +133,444 +774%
Brown Advisory
52
Brown Advisory
Maryland
$4.92M +$5.13M +149,831 New
MICM
53
Matthews International Capital Management
California
$4.89M +$17.1K +500 +0.3%
Boston Partners
54
Boston Partners
Massachusetts
$4.78M -$2.27M -66,214 -31%
ACI
55
AMP Capital Investors
Australia
$4.68M +$3.19M +93,200 +198%
IAM
56
Integre Asset Management
New York
$4.21M -$360K -10,532 -8%
Renaissance Technologies
57
Renaissance Technologies
New York
$4.19M +$503K +14,699 +13%
CCM
58
Causeway Capital Management
California
$4.14M -$1.08M -31,500 -20%
BTS
59
BB&T Securities
Virginia
$3.98M -$392K -11,454 -49%
SR
60
Sloane Robinson
United Kingdom
$3.94M -$1.37M -40,100 -25%
OSAM
61
O'Shaughnessy Asset Management
Connecticut
$3.67M -$279K -8,144 -7%
New York State Common Retirement Fund
62
New York State Common Retirement Fund
New York
$3.61M +$2.71M +79,062 +258%
Wells Fargo
63
Wells Fargo
California
$3.43M -$458K -13,377 -11%
RSCM
64
Rock Springs Capital Management
Maryland
$3.17M +$1.51M +44,000 +84%
U
65
UBS
Switzerland
$3.12M +$83.9K +2,451 +3%
Royal Bank of Canada
66
Royal Bank of Canada
Ontario, Canada
$3.06M +$1.4M +40,806 +78%
Millennium Management
67
Millennium Management
New York
$3.03M +$3.15M +92,174 New
RSS
68
Rosenblum Silverman Sutton
California
$2.95M -$56.5K -1,650 -2%
GF
69
Gabelli Funds
New York
$2.83M – – –
VCAM
70
Valentine Capital Asset Management
California
$2.67M +$2.78M +81,300 New
GC
71
Gratry & Company
Ohio
$2.66M -$3.78M -110,474 -58%
ERSOT
72
Employees Retirement System of Texas
Texas
$2.58M -$342K -10,000 -11%
BA
73
BlackRock Advisors
Delaware
$2.49M -$2.12M -61,926 -45%
GPCM
74
Granite Point Capital Management
Massachusetts
$2.3M -$1.1M -32,000 -31%
State of New Jersey Common Pension Fund D
75
State of New Jersey Common Pension Fund D
New Jersey
$2.03M +$2.11M +61,800 New
1 2
3
4 5

WX Hedge Fund Activity: Q2 2014 in Review

154 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q2 2014, worth a combined $1.91B — down 12% from $2.17B a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of WX and 16 opened new positions — a net loss of 10 holders — while 66 trimmed existing stakes and 57 added.

The largest buyer was Wellington Management Group, adding an estimated $82.7M. The largest seller was CI Investments Inc, exiting entirely with an estimated $54.7M sold.

  • 154 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q2 2014, down from 164 in Q1 2014.
  • Funds reported $1.91B of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q2 2014, down 12% quarter-over-quarter.
  • 16 funds opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q2 2014 and 26 closed out, a net change of -10 holders.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q2 2014 was Wellington Management Group, an estimated $82.7M added.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q2 2014 was CI Investments Inc, an estimated $54.7M sold.

Based on aggregated 13F filings for Q2 2014.